The Merck acquisition of Schering-Plough may have surprised few, the approach has raised some
eyebrows. Rather than buy the company outright, Merck going through a convoluted reverse merger deal to keep
Schering’s licensing deals secure. Was it the right move?
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
